Christian Rothermundt Selected Research

Christian Rothermundt Research Topics

Disease

9	Prostatic Neoplasms (Prostate Cancer) 08/2019 - 11/2012
6	Neoplasms (Cancer) 07/2022 - 07/2013
6	Sarcoma (Soft Tissue Sarcoma) 07/2022 - 09/2012
6	Renal Cell Carcinoma (Grawitz Tumor) 01/2022 - 01/2012
4	Disease Progression 10/2017 - 11/2012
3	Testicular Neoplasms (Testicular Cancer) 06/2022 - 06/2010
2	Seminoma 06/2022 - 01/2018
1	Leukemia 07/2022
1	Rhabdomyosarcoma 07/2022
1	COVID-19 01/2020
1	Circulating Neoplastic Cells 08/2019
1	Neoplasm Metastasis (Metastasis) 01/2019
1	Hyperthermia 01/2018
1	Neutropenia 10/2017
1	Fatigue 10/2017
1	Fever (Fevers) 10/2017
1	Stomatitis 10/2017
1	Febrile Neutropenia 10/2017
1	Pain (Aches) 10/2017
1	Adrenal Insufficiency (Adrenal Gland Hypofunction) 12/2016
1	Pneumonia (Pneumonitis) 12/2016
1	Lymphoma (Lymphomas) 01/2016
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2016
1	Restless Legs Syndrome (Restless Legs) 10/2015
1	Peripheral Nervous System Diseases (PNS Diseases) 08/2015
1	Dysgeusia (Parageusia) 08/2015
1	Alopecia (Baldness) 08/2015
1	Osteosarcoma (Osteogenic Sarcoma) 01/2015
1	Diabetes Mellitus 09/2014
1	Adenocarcinoma 05/2013
1	Angioedema 02/2013
1	Hepatitis B 07/2010
1	Sexually Transmitted Diseases (Sexually Transmitted Disease) 07/2010
1	Needlestick Injuries (Needlestick Injury) 07/2010
1	Infections 07/2010
1	Jaundice (Icterus) 07/2010
1	Bites and Stings (Sting) 07/2010
1	Ovarian Epithelial Carcinoma 12/2008
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 08/2006

Drug/Important Bio-Agent (IBA)

6	Docetaxel (Taxotere)FDA Link 01/2019 - 11/2012
3	enzalutamideIBA 08/2019 - 10/2015
3	Prostate-Specific Antigen (Semenogelase)IBA 01/2019 - 11/2012
2	Sunitinib (Sutent)FDA Link 01/2020 - 01/2012
2	Tyrosine Kinase InhibitorsIBA 01/2020 - 01/2015
2	Pharmaceutical PreparationsIBA 12/2019 - 09/2014
2	AndrogensIBA 08/2019 - 12/2016
2	Metformin (Glucophage)FDA LinkGeneric 01/2019 - 09/2014
2	abirateroneIBA 01/2019 - 01/2019
2	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2017 - 09/2012
2	Rituximab (Mabthera)FDA Link 01/2016 - 08/2006
2	Sorafenib (BAY 43-9006)FDA Link 01/2015 - 01/2012
2	Everolimus FDA Link 07/2013 - 02/2013
1	ParaffinIBA 07/2022
1	Proteins (Proteins, Gene)FDA Link 07/2022
1	RNA (Ribonucleic Acid)IBA 07/2022
1	Protein Isoforms (Isoforms)IBA 07/2022
1	Tumor Biomarkers (Tumor Markers)IBA 06/2022
1	Keratins (Keratin)IBA 01/2021
1	pazopanib FDA Link 01/2020
1	IpilimumabIBA 01/2020
1	Immune Checkpoint InhibitorsIBA 01/2020
1	NivolumabIBA 01/2020
1	Androgen Receptors (Androgen Receptor)IBA 08/2019
1	Indicators and Reagents (Reagents)IBA 01/2018
1	Gemcitabine FDA Link 10/2017
1	orteronelIBA 12/2016
1	Lenalidomide (CC 5013)FDA Link 01/2016
1	Bendamustine Hydrochloride FDA Link 01/2016
1	AnthracyclinesIBA 01/2016
1	cabazitaxel FDA Link 08/2015
1	Denosumab FDA Link 01/2015
1	RANK LigandIBA 01/2015
1	Biomarkers (Surrogate Marker)IBA 07/2013
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 07/2013
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 07/2013
1	TensinsIBA 07/2013
1	Sirolimus (Rapamycin)FDA Link 07/2013
1	Anaplastic Lymphoma KinaseIBA 05/2013
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 02/2013
1	Cetuximab (Erbitux)FDA Link 11/2012
1	ErbB Receptors (EGF Receptor)IBA 11/2012
1	Monoclonal AntibodiesIBA 11/2012
1	Etoposide (VP 16)FDA LinkGeneric 09/2012
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 09/2012
1	Vincristine (Oncovin)FDA LinkGeneric 09/2012
1	Ifosfamide FDA LinkGeneric 09/2012
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2012
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 07/2010

Therapy/Procedure

12	Therapeutics 07/2022 - 12/2008
11	Drug Therapy (Chemotherapy) 07/2022 - 12/2008
7	Castration 08/2019 - 11/2012
3	Adjuvant Chemotherapy 06/2022 - 02/2015
1	Orchiectomy (Orchidectomy) 06/2022
1	Nephrectomy 01/2022
1	Neoadjuvant Therapy 01/2018
1	Radiotherapy 01/2018
1	Body Piercing (Piercing, Body) 07/2010